These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21517771)

  • 1. Impacts of nanotechnology on medicinal chemistry and drug discovery.
    Yan B
    Curr Med Chem; 2011; 18(14):2044. PubMed ID: 21517771
    [No Abstract]   [Full Text] [Related]  

  • 2. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.
    Havel HA
    AAPS J; 2016 Nov; 18(6):1351-1353. PubMed ID: 27520380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-by-design of nanopharmaceuticals - a state of the art.
    Bastogne T
    Nanomedicine; 2017 Oct; 13(7):2151-2157. PubMed ID: 28579437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainable practices in medicinal chemistry: current state and future directions.
    Bryan MC; Dillon B; Hamann LG; Hughes GJ; Kopach ME; Peterson EA; Pourashraf M; Raheem I; Richardson P; Richter D; Sneddon HF
    J Med Chem; 2013 Aug; 56(15):6007-21. PubMed ID: 23586692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2
    Aldrich CC; Calderón F
    ACS Infect Dis; 2018 Apr; 4(4):424-428. PubMed ID: 29649878
    [No Abstract]   [Full Text] [Related]  

  • 6. Preface to this special issue on chemical biology and drug discovery.
    Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1561-2. PubMed ID: 26305581
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes.
    Elzoghby AO
    Nanomedicine (Lond); 2019 Mar; 14(6):649-653. PubMed ID: 30693819
    [No Abstract]   [Full Text] [Related]  

  • 8. Current tendencies in antimicrobial research: medicinal chemistry of antibacterial agents and advances in the use of computational methodologies.
    Scotti MT; Cordeiro MN; Speck-Planche A
    Curr Top Med Chem; 2013; 13(24):3011-2. PubMed ID: 24200364
    [No Abstract]   [Full Text] [Related]  

  • 9. Data-driven medicinal chemistry in the era of big data.
    Lusher SJ; McGuire R; van Schaik RC; Nicholson CD; de Vlieg J
    Drug Discov Today; 2014 Jul; 19(7):859-68. PubMed ID: 24361338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
    Sneddon H
    Future Med Chem; 2014; 6(12):1373-6. PubMed ID: 25329193
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing nanomedicine.
    Kostarelos K
    Nanomedicine (Lond); 2006 Oct; 1(3):259-60. PubMed ID: 17716156
    [No Abstract]   [Full Text] [Related]  

  • 12. There is no better time than the present: nanotechnology as a disruptive innovation for drug development.
    Oo C; Tsai JC; Kao HD
    Drug Discov Today; 2015 Jun; 20(6):645-7. PubMed ID: 25835226
    [No Abstract]   [Full Text] [Related]  

  • 13. Transforming fragments into candidates: small becomes big in medicinal chemistry.
    de Kloe GE; Bailey D; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Jul; 14(13-14):630-46. PubMed ID: 19443265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free technologies and pharmacology.
    Fang Y
    Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicinal chemistry and the pharmacy curriculum.
    Khan MO; Deimling MJ; Philip A
    Am J Pharm Educ; 2011 Oct; 75(8):161. PubMed ID: 22102751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdisciplinary chemical approaches for neuropathology.
    Ramsay RR; Di Giovanni G
    CNS Neurosci Ther; 2014 Jul; 20(7):571-3. PubMed ID: 24935786
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 18. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of chemical diversity.
    Triggle DJ
    Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 21971814
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicochemical descriptors of aromatic character and their use in drug discovery.
    Ritchie TJ; Macdonald SJ
    J Med Chem; 2014 Sep; 57(17):7206-15. PubMed ID: 24856517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.